Few grocery-store mysteries can raise a parent’s blood pressure faster than an empty baby formula shelf. One minute you are shopping like a calm, capable adult. The next, you are staring at a lonely price tag where your baby’s formula should be, wondering whether the store is hiding cans in the back like a secret cheese cave. So, why is there a formula shortage? The answer is not one villain twirling a mustache in aisle seven. It is a pileup of safety recalls, factory shutdowns, supply chain fragility, market concentration, strict import rules, WIC purchasing rules, and panic buying that turns a normal shortage into a national scavenger hunt.
The most severe U.S. infant formula shortage happened in 2022, but the lessons still matter. Formula is not like swapping one brand of paper towels for another. Babies may need specific products because of allergies, digestion issues, premature birth, metabolic conditions, or medical advice. When the supply chain wobbles, families do not simply “try something else.” They call pediatricians, refresh store websites, text relatives in other states, and sometimes drive farther for formula than anyone should have to drive for anything that comes in a scoop.
This guide breaks down the real causes behind baby formula shortages in the United States, why the 2022 crisis became so serious, what has improved since then, and why the system still needs backup plans that are sturdier than “hope the truck arrives Tuesday.”
The Short Answer: Formula Shortages Happen When a Fragile System Gets Hit Too Hard
A formula shortage usually begins when demand and supply fall out of balance. That sounds simple, but the infant formula market is unusually sensitive. The product must meet strict nutrition and safety standards. A small group of companies makes most of the formula. A handful of factories produce huge volumes. Many families depend on WIC benefits, which often tie shoppers to approved brands and package sizes. Imports have historically been limited by U.S. labeling, nutrient, and regulatory requirements. Add a major recall or plant closure, and suddenly the whole system behaves like a toddler tower made of blocks: impressive until one block goes missing.
In 2022, the shortage was driven by several shocks at once. Pandemic-era supply chain problems had already made ingredients, packaging, labor, and transportation less predictable. Then Abbott Nutrition recalled certain powdered formulas made at its Sturgis, Michigan facility after federal investigations into Cronobacter infections and related safety concerns. The Sturgis plant temporarily stopped production, removing a major source of U.S. formula from shelves. Other manufacturers increased output, but they could not instantly replace that lost capacity. Formula production is not a pancake mix situation. You cannot just add another griddle and shout, “More scoops!”
The Abbott Recall and Sturgis Shutdown: The Spark That Lit the Fire
The most visible trigger of the 2022 baby formula shortage was the recall of certain Similac, Alimentum, and EleCare powdered formulas made at Abbott’s Sturgis facility. The FDA investigated reports of Cronobacter sakazakii infections in infants who had consumed formula from that facility. Abbott voluntarily recalled affected products, and production at the plant was paused while safety issues were addressed.
That shutdown mattered because the Sturgis facility was not a tiny boutique formula kitchen making three cans and a dream. It was a major production site, including for specialty formulas used by infants with serious medical or dietary needs. When a plant like that goes offline, the shortage hits more than ordinary shelves. Hospitals, pediatric practices, and families using hypoallergenic or metabolic formulas feel the squeeze quickly.
Why a Safety Recall Can Create a Supply Crisis
Food safety rules are strict for a reason. Infant formula may be the sole source of nutrition for babies during a vulnerable stage of life. If there are contamination risks or serious manufacturing concerns, regulators and manufacturers have to act. But when the market is concentrated and inventories are lean, a necessary recall can ripple through the country.
The hard truth is that safety and supply are not separate issues. Parents need formula that is available, but they also need formula that is safe. A strong formula system must do both: prevent contamination and preserve enough backup capacity so one recall does not turn into a nationwide emergency.
Market Concentration: Too Many Eggs in Too Few Formula Baskets
One of the biggest reasons the formula shortage became so painful is that the U.S. infant formula industry is highly concentrated. A few major manufacturers account for most sales. That can be efficient during normal times, but it becomes risky during a disruption. If one large producer loses capacity, the remaining companies may not be able to fill the gap immediately.
Think of it like a school bake sale where three parents bring 90 percent of the cupcakes. If one parent’s oven breaks, everyone suddenly learns math through frosting panic. The formula market had a similar vulnerability: large-scale production, limited redundancy, and little spare capacity sitting around unused.
Market concentration also affects distribution. Retailers may depend heavily on established brands. Pediatricians may recommend familiar formulas. WIC programs often authorize specific contract brands by state. All of that can make the system efficient on paper but stiff in a crisis.
WIC Rules Help Families Afford Formula, But They Can Limit Flexibility During Shortages
The Special Supplemental Nutrition Program for Women, Infants, and Children, better known as WIC, is a lifeline for many families. It helps low-income pregnant people, infants, and young children access nutritious food, including infant formula. WIC is not the villain in the formula shortage story. It is a vital program. However, the way WIC formula contracts work can shape the market.
States typically contract with a formula manufacturer in exchange for rebates. In practice, that often means WIC shoppers in a state are directed to specific brands and sizes. During normal times, this helps control government costs and improves access. During a shortage, though, rigid brand rules can leave families standing in front of a shelf that contains formula they are not authorized to buy.
During the 2022 crisis, USDA and state agencies issued waivers so WIC families could buy alternative sizes, forms, or brands when their usual product was unavailable. Those flexibilities helped, but they also revealed the core problem: emergency flexibility should not have to be invented while parents are already panicking.
Imports Were Not Easy to Turn On Overnight
Another reason the U.S. shortage dragged on is that imported formula could not simply flood the shelves immediately. U.S. infant formula rules cover nutrition, safety, labeling, and manufacturing. Those standards are important, but they can also make it hard for foreign manufacturers to enter the market quickly, even when their products are widely used in places like Europe.
During the 2022 shortage, the federal government temporarily allowed some foreign-made formulas into the U.S. under enforcement discretion, and Operation Fly Formula brought in shipments from overseas. Those emergency imports helped ease pressure, especially for certain specialty formulas. Still, airlifting formula is a dramatic solution. It belongs in the “thank goodness it exists” category, not the “this is how a stable baby food system should work every month” category.
Pandemic Supply Chain Problems Made Everything Worse
Before the recall, the formula market was already dealing with COVID-era supply chain trouble. Manufacturers faced disruptions in ingredients, packaging, labor availability, shipping, trucking, and warehouse operations. Demand also behaved strangely. At times, families bought extra formula because they feared shortages. Later, buying patterns shifted again. Producers had to forecast demand in a world where every spreadsheet looked like it had been sneezed on.
Formula manufacturing depends on a long chain of inputs: dairy ingredients, oils, vitamins, minerals, packaging materials, labels, lids, quality testing, and distribution. A shortage of one component can delay the whole product. You may have enough powder but not enough cans. You may have cans but not the right labels. You may have everything made, then struggle to move it to the right store at the right time. Supply chains love boring predictability. The pandemic handed them a kazoo and a roller coaster.
Panic Buying Turned Empty Spots Into Empty Aisles
When parents see a product disappearing, buying extra feels rational. If your baby eats the same formula every day and you see three cans left, you may buy all three. That does not make you selfish; it makes you a parent trying to sleep tonight. But when thousands of families do the same thing, shelves empty faster than suppliers can restock.
Retailers responded by setting purchase limits, but those limits were inconsistent. Some parents visited several stores to get enough formula. Others asked grandparents, cousins, coworkers, and online parenting groups to search in different towns. The shortage became partly a logistics problem and partly a trust problem. Once families believed formula might not be available tomorrow, normal shopping behavior disappeared.
Specialty Formula Shortages Hit Families the Hardest
Not all formula shortages feel the same. A family using standard cow’s-milk-based formula may have several possible substitutes, although they should still check with a pediatrician when switching. A family using hypoallergenic, amino-acid-based, premature infant, or metabolic formula may have far fewer options. For these babies, switching products is not like choosing a new cereal because the old one stopped being fun.
Specialty formula shortages caused some of the most serious stress in 2022. Parents of babies with allergies, digestive disorders, metabolic conditions, or medically fragile needs often depend on specific products. Hospitals and pediatric specialists had to help families identify safe substitutes. This is why formula resilience is not just a grocery issue. It is a public health issue.
Regulatory Delays and Communication Problems Added to the Crisis
Several reviews after the 2022 shortage found that the U.S. response needed better coordination, faster communication, and stronger visibility into the formula supply chain. The FDA has since released strategies focused on preventing contamination, improving supply resiliency, strengthening information sharing, supporting new market entrants, and coordinating with other federal agencies.
That matters because during a shortage, timing is everything. If regulators, manufacturers, retailers, doctors, and WIC agencies do not receive clear information quickly, families get mixed messages. One parent hears a formula is safe. Another sees a recall post. A third cannot tell whether a substitute is appropriate. In that confusion, the internet becomes both a support group and a rumor blender.
Has the Formula Shortage Been Fixed?
The U.S. formula supply is more stable now than it was during the worst months of 2022. Federal agencies have taken steps to improve oversight, encourage more market resilience, and make emergency responses smoother. More attention is being paid to specialty formulas, contamination prevention, and supply chain visibility.
However, “better” does not mean “bulletproof.” Recalls, storms, factory problems, raw material issues, or transportation disruptions can still cause local or brand-specific shortages. In late 2025, for example, ByHeart recalled formula after a botulism investigation. Because ByHeart represented a small share of the total U.S. formula market, regulators did not expect that recall to create a broad national shortage. That is an important lesson: the impact of a recall depends on how much of the market the recalled product represents and whether alternatives are available.
What Parents Should Do During a Formula Shortage
Parents should avoid dangerous shortcuts. Do not dilute formula to make it last longer. Do not make homemade infant formula. Do not give cow’s milk to young infants unless a healthcare professional specifically advises it for a short-term emergency. Do not buy formula from unknown sellers where storage, tampering, or expiration cannot be verified. The goal is not just to find calories. The goal is to safely feed a baby whose nutrition needs are precise.
Instead, call the baby’s pediatrician, especially if the baby uses a specialty formula. Ask about safe alternatives in the same category. Check official recall pages before using unfamiliar products. Search multiple reputable retailers, but avoid hoarding more than a reasonable supply. Families using WIC should contact their local WIC office to learn what substitutions are allowed during shortages. Hospitals, pediatric dietitians, and local health departments may also know where specialty products are available.
What Would Prevent the Next Formula Shortage?
Preventing future formula shortages requires more than asking parents to be patient. The system needs structural improvements. First, the market needs more redundancy, including more manufacturers and more geographically diverse production. Second, the government and industry need earlier warning systems for supply disruptions. Third, WIC rules need built-in emergency flexibility so families can switch approved products quickly when a contract brand is unavailable.
Fourth, import pathways should be clearer before an emergency. The U.S. should not have to reinvent international sourcing while parents are posting desperate messages at midnight. Fifth, regulators and manufacturers need fast, transparent communication about recalls, substitutes, and safety. Finally, specialty formula planning must be treated as essential healthcare infrastructure, not as a side note in the baby aisle.
Real-World Experiences: What the Formula Shortage Felt Like for Families
For many families, the formula shortage was not an abstract headline. It was a daily routine with all the charm of a broken vending machine. Parents woke up early to check store apps. They learned delivery schedules for local supermarkets. They called pharmacies, big-box stores, pediatric offices, and friends across town. Some drove from one county to another only to find that the website’s “in stock” label meant “was here three hours ago, good luck.”
One common experience was the emotional whiplash of finding a can, then feeling guilty for buying it. Parents needed enough formula to feed their own baby, but they also knew another family might be searching. Purchase limits helped reduce hoarding, yet they created new challenges for families who lived far from stores or had limited transportation. Buying two cans at a time is manageable when the store is five minutes away. It is a much bigger problem when the trip requires gas money, time off work, or help from someone with a car.
Another experience was the stress of switching formulas. Some babies tolerate changes easily. Others do not. Parents reported worrying about spit-up, constipation, fussiness, allergic reactions, and whether a substitute would work. The pressure was especially intense for caregivers of babies using hypoallergenic or medical formulas. These families could not simply grab whatever was on the shelf. Their shopping list came with a medical footnote, and the shelf did not always care.
The shortage also exposed how uneven access can be. A family with flexible work hours, reliable transportation, online shopping accounts, and relatives in three states had more options than a family relying on one nearby store and WIC-approved products. Rural families faced long drives. Urban families faced sold-out shelves. Low-income families faced the cruel math of price spikes, limited substitutions, and transportation costs. A formula shortage is not just about cans. It is about time, money, mobility, information, and social support.
Online parent groups became emergency networks. People posted photos of shelves, shared store locations, traded unopened cans, and warned others about scams. Some communities organized donation drives. Pediatricians and nurses spent extra time answering feeding questions. In the middle of a frightening situation, many people showed up for each other. That part matters. The shortage revealed weaknesses in the supply chain, but it also revealed how quickly ordinary people can build a human supply chain when the official one sputters.
Still, families should not have to rely on luck, Facebook posts, or a cousin in Ohio to feed a baby. The lesson from these experiences is clear: formula is essential, and essential products need resilient systems. Parents can be resourceful, but resourcefulness is not a national policy. A stronger formula market should make emergency scrambling rare, not routine.
Conclusion: The Formula Shortage Was a Warning, Not a One-Time Fluke
So, why is there a formula shortage? Because the U.S. infant formula system has historically depended on a small number of manufacturers, limited production redundancy, complicated purchasing rules, strict import pathways, and supply chains that can break under pressure. The 2022 crisis became severe when pandemic disruptions collided with a major recall and the temporary shutdown of a key Abbott plant. Later improvements have made the market more stable, but the basic lesson remains: babies need a supply chain with backup plans.
The solution is not to weaken safety standards or tell parents to calm down. The solution is to build a safer, more competitive, more flexible system that can absorb recalls, storms, factory problems, and sudden demand spikes without sending families on a cross-state treasure hunt for a can of powder. Formula should be boringly available. For parents, boring is beautiful.
